Drug Recalls



Eliquis – Bristol-Myers Squibb

On June 13, 2017 the U.S. Food and Drug Administration (FDA) announced that Bristol-Myers Squibb initiated a voluntary recall of one lot of Eliquis 5mg tablets. This recall is on the following lot: HN0063. This recall has been initiated as a precautionary measure based on a customer complaint that a bottle labeled as Eliquis 5mg was found to contain Eliquis 2.5mg tablets.

There are distinct visible differences between the two tablet strengths including colors, size and markings that distinguish the 2.5 mg and 5 mg tablets and decrease the likelihood of an incorrect dose. The 2.5 mg presentation is a yellow, round, biconvex, film-coated tablet with “893” debossed on one side and “2½” on the other side. The 5 mg presentation is a pink, oval, biconvex, film-coated tablet with “894” debossed on one side and “5” on the other side.

Patients should not stop taking Eliquis without consulting with their physician. Eliquis tablets are indicated to reduce the risk of stroke and blood clots in people who have atrial fibrillation; it also treats blood clots in the veins of your legs or lungs as well as reduces the risk of forming a blood clot in the legs and lungs of people who have just had hip or knee replacement surgery.

You should contact your physician or healthcare provider if you have experienced any problems that may be related to taking or using this medication.


EpiPen and EpiPen Jr. Auto Injectors - Meridian Medical Technologies

On March 31, 2017 the U.S. Food and Drug Administration (FDA) announced that Meridian Medical Technologies, a Pfizer and Mylan manufacturing partner, initiated a voluntary recall of select lots of EpiPen and EpiPen Jr Auto-Injectors. This recall includes the following lot numbers:

Product/Dosage NDC Number Lot Number Expiration Date
EpiPen Jr Auto-Injector, 0.15 mg 49502-501-02 5GN767 April 2017
EpiPen Jr Auto-Injector, 0.15 mg 49502-501-02 5GN773 April 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 5GM631 April 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 5GM640 May 2017
EpiPen Jr Auto-Injector, 0.15 mg 49502-501-02 6GN215 September 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM082 September 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM072 September 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM081 September 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM088 October 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM199 October 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM091 October 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM198 October 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM087 October 2017

This recall has been initiated due to the potential that these devices may contain a defective part that may result in the devices’ failure to activate. While the number of reported failures is small, EpiPen products that potentially contain a defective part are being recalled because of the potential for life-threatening risk if a severe allergic reaction goes untreated. Consumers should keep and use their current EpiPens if needed until they get a replacement. Consumers should contact Stericycle at 1-877-650-3494.

You should contact your physician or healthcare provider if you have experienced any problems that may be related to taking or using this medication.



Last updated: 7/12/2017